|
US9266891B2
(en)
|
2012-11-16 |
2016-02-23 |
Boehringer Ingelheim International Gmbh |
Substituted [1,2,4]triazolo[4,3-A]pyrazines that are BRD4 inhibitors
|
|
EP2935253B1
(en)
|
2012-12-21 |
2018-08-01 |
Zenith Epigenetics Ltd. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
WO2015004533A2
(en)
|
2013-06-21 |
2015-01-15 |
Zenith Epigenetics Corp. |
Novel substituted bicyclic compounds as bromodomain inhibitors
|
|
WO2015002754A2
(en)
|
2013-06-21 |
2015-01-08 |
Zenith Epigenetics Corp. |
Novel bicyclic bromodomain inhibitors
|
|
GB201311888D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
GB201311891D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel compound
|
|
WO2015015318A2
(en)
|
2013-07-31 |
2015-02-05 |
Zenith Epigenetics Corp. |
Novel quinazolinones as bromodomain inhibitors
|
|
RS63733B1
(sr)
|
2013-10-18 |
2022-12-30 |
Celgene Quanticel Research Inc |
Inhibitori bromodomena
|
|
NZ719465A
(en)
*
|
2013-11-26 |
2017-03-31 |
Gilead Sciences Inc |
Quinoline derivatives as bromodomain inhibitors
|
|
ES2809535T3
(es)
*
|
2013-12-09 |
2021-03-04 |
UCB Biopharma SRL |
Derivados de imidazopiridina como moduladores de la actividad de TNF
|
|
GB201321737D0
(en)
*
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic Agents
|
|
US20180228907A1
(en)
|
2014-04-14 |
2018-08-16 |
Arvinas, Inc. |
Cereblon ligands and bifunctional compounds comprising the same
|
|
WO2016087942A1
(en)
|
2014-12-01 |
2016-06-09 |
Zenith Epigenetics Corp. |
Substituted pyridines as bromodomain inhibitors
|
|
WO2016087936A1
(en)
|
2014-12-01 |
2016-06-09 |
Zenith Epigenetics Corp. |
Substituted pyridinones as bromodomain inhibitors
|
|
US10292968B2
(en)
|
2014-12-11 |
2019-05-21 |
Zenith Epigenetics Ltd. |
Substituted heterocycles as bromodomain inhibitors
|
|
US10231953B2
(en)
|
2014-12-17 |
2019-03-19 |
Zenith Epigenetics Ltd. |
Inhibitors of bromodomains
|
|
GB201503720D0
(en)
*
|
2015-03-05 |
2015-04-22 |
Glaxosmithkline Ip No 2 Ltd |
Chemical compound
|
|
CA2979070A1
(en)
|
2015-03-18 |
2016-09-22 |
Arvinas, Inc. |
Compounds and methods for the enhanced degradation of targeted proteins
|
|
GB201504689D0
(en)
*
|
2015-03-19 |
2015-05-06 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
GB201504694D0
(en)
|
2015-03-19 |
2015-05-06 |
Glaxosmithkline Ip Dev Ltd |
Covalent conjugates
|
|
GB201506660D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
CN108350062B
(zh)
|
2015-08-06 |
2022-10-14 |
达纳-法伯癌症研究所股份有限公司 |
靶向蛋白降解以减弱过继性t细胞疗法相关的不良炎症反应
|
|
WO2017024406A1
(en)
|
2015-08-11 |
2017-02-16 |
Neomed Institute |
N-substituted bicyclic lactams, their preparation and their use as pharmaceuticals
|
|
CN108290856A
(zh)
|
2015-08-11 |
2018-07-17 |
尼奥迈德研究所 |
芳基-取代的二氢喹诺酮、它们的制备和它们作为药物的用途
|
|
AU2016305515A1
(en)
|
2015-08-12 |
2018-03-08 |
Neomed Institute |
Substituted benzimidazoles, their preparation and their use as pharmaceuticals
|
|
EP3337476A4
(en)
|
2015-08-19 |
2019-09-04 |
Arvinas, Inc. |
Compounds and methods for the targeted degradation of bromodomain-containing proteins
|
|
WO2017066876A1
(en)
|
2015-10-21 |
2017-04-27 |
Neomed Institute |
Substituted imidazopyridines, their preparation and their use as pharmaceuticals
|
|
CA3007168A1
(en)
*
|
2015-12-14 |
2017-06-22 |
Zenith Epigenetics Ltd. |
1h-imidazo[4,5-b]pyridinyl and 2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridinyl heterocyclic bet bromodomain inhibitors
|
|
US10519151B2
(en)
|
2016-01-28 |
2019-12-31 |
Neomed Institute |
Substituted [1,2,4]triazolo[4,3-A]pyridines, their preparation and their use as pharmaceuticals
|
|
WO2017172914A1
(en)
|
2016-03-30 |
2017-10-05 |
Wisconsin Alumni Research Foundation |
Methods and compositions for modulating frataxin expression
|
|
CN109641874A
(zh)
|
2016-05-10 |
2019-04-16 |
C4医药公司 |
用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
|
|
WO2017197055A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
Heterocyclic degronimers for target protein degradation
|
|
CN109790143A
(zh)
|
2016-05-10 |
2019-05-21 |
C4医药公司 |
用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体
|
|
EP3454862B1
(en)
|
2016-05-10 |
2024-09-11 |
C4 Therapeutics, Inc. |
Spirocyclic degronimers for target protein degradation
|
|
GB201614939D0
(en)
*
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Ip Dev Ltd |
Crystalline hydrate
|
|
GB201614940D0
(en)
*
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Chemical compounds
|
|
WO2018106667A1
(en)
|
2016-12-05 |
2018-06-14 |
Microbiotix, Inc. |
Broad-spectrum inhibitors of filoviruses
|
|
CN110612294B
(zh)
|
2017-01-31 |
2024-01-16 |
阿尔维纳斯运营股份有限公司 |
人小脑蛋白配体和包含其的双官能化合物
|
|
WO2018148440A1
(en)
|
2017-02-08 |
2018-08-16 |
Dana-Farber Cancer Institute, Inc. |
Regulating chimeric antigen receptors
|
|
WO2018183679A1
(en)
|
2017-03-29 |
2018-10-04 |
Wisconsin Alumni Research Foundation |
Methods and compositions for modulating gene expression
|
|
CN110769822A
(zh)
|
2017-06-20 |
2020-02-07 |
C4医药公司 |
用于蛋白降解的n/o-连接的降解决定子和降解决定子体
|
|
CN109111437B
(zh)
*
|
2017-06-22 |
2022-03-04 |
中国科学院广州生物医药与健康研究院 |
一种苯并[d]异恶唑类化合物及其制备方法和应用
|
|
CN109280046B
(zh)
*
|
2017-07-21 |
2021-02-02 |
浙江海正药业股份有限公司 |
苯并咪唑类衍生物及其制备方法及其在医药上的用途
|
|
US11447466B2
(en)
*
|
2017-08-04 |
2022-09-20 |
Bristol-Myers Squibb Company |
Substituted indole compounds useful as inhibitors of TLR7/8/9
|
|
WO2019145410A1
(en)
*
|
2018-01-25 |
2019-08-01 |
Boehringer Ingelheim International Gmbh |
Combination treatment of acute myeloid leukemia
|
|
US11220515B2
(en)
|
2018-01-26 |
2022-01-11 |
Yale University |
Imide-based modulators of proteolysis and associated methods of use
|
|
US10442799B1
(en)
|
2018-04-07 |
2019-10-15 |
Fuqiang Ruan |
Heterocyclic compounds and uses thereof
|
|
MX2020010571A
(es)
|
2018-04-13 |
2021-01-08 |
Arvinas Operations Inc |
Ligandos de cereblon y compuestos bifuncionales que los comprenden.
|
|
CN120698985A
(zh)
|
2018-12-20 |
2025-09-26 |
C4医药公司 |
靶向蛋白降解
|
|
JP2022053557A
(ja)
*
|
2019-02-08 |
2022-04-06 |
マルホ株式会社 |
ピリドン誘導体
|
|
EP4424379A3
(en)
*
|
2019-04-24 |
2024-10-30 |
Convergene Llc |
Small molecule bromodomain inhibitors and uses thereof
|
|
CA3152923A1
(en)
|
2019-09-30 |
2021-04-08 |
Keisuke Yamamoto |
Bet degrader
|
|
CN115175901B
(zh)
|
2019-12-19 |
2024-03-22 |
阿尔维纳斯运营股份有限公司 |
用于雄激素受体的靶向降解的化合物和方法
|
|
WO2021175432A1
(en)
|
2020-03-04 |
2021-09-10 |
Boehringer Ingelheim International Gmbh |
Method for administration of an anti cancer agent
|
|
WO2024050016A1
(en)
|
2022-08-31 |
2024-03-07 |
Oerth Bio Llc |
Compositions and methods for targeted inhibition and degradation of proteins in an insect cell
|
|
WO2025049555A1
(en)
|
2023-08-31 |
2025-03-06 |
Oerth Bio Llc |
Compositions and methods for targeted inhibition and degradation of proteins in an insect cell
|